Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
18.6M
-
Shares change
-
+243K
-
Total reported value, excl. options
-
$62.7M
-
Value change
-
-$726K
-
Number of buys
-
30
-
Number of sells
-
-13
-
Price
-
$3.37
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2015
56 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2015.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.6M shares
of 114M outstanding shares and own 16.28% of the company stock.
Largest 10 shareholders include FMR LLC (4.31M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.6M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), Redmile Group, LLC (2.37M shares), WELLINGTON MANAGEMENT GROUP LLP (1.31M shares), Broadfin Capital, LLC (1.11M shares), ORBIMED ADVISORS LLC (693K shares), FRANKLIN RESOURCES INC (500K shares), VANGUARD GROUP INC (415K shares), and PRINCIPAL FINANCIAL GROUP INC (351K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.